Who is sponsoring NCT06123520?

NCT06123520 is sponsored by Ain Shams University.

What drugs are being tested in NCT06123520?

Interventions in NCT06123520: Ho-YAG Laser Visual internal urethrotomy, Ho-YAG Laser Visual internal urethrotomy combined with intralesional submucosal injection of Paclitaxel.

What condition does NCT06123520 study?

NCT06123520 studies Urethral Stricture, Male.

Is NCT06123520 still recruiting?

NCT06123520 is currently completed. Last updated 8 November 2023.

Last reviewed 2023-11-08 · How we verify

NCT06123520

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laser Visual Internal Urethrotomy With Versus Without Paclitaxel Injection

Completed Phase 3 Last updated 8 November 2023

What this trial tests

Phase 3 trial testing Ho-YAG Laser Visual internal urethrotomy in Urethral Stricture, Male in 60 participants. Completed in 15 October 2023.

Timeline

1 May 2023

Primary endpoint
1 October 2023

15 October 2023

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 3
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 May 2023
Primary completion	1 October 2023
Estimated completion	15 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

Ho-YAG Laser Visual internal urethrotomy
Ho-YAG Laser Visual internal urethrotomy combined with intralesional submucosal injection of Paclitaxel

Conditions studied

Urethral Stricture, Male — all drugs for Urethral Stricture, Male →

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, male only, with Urethral Stricture, Male. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the outcome of visual internal urethrotomy in treating urethral strictures in males with a holmium: yttrium-aluminium garnet (YAG) laser versus when combined with intralesional injection of paclitaxel.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Urethral Stricture, Male

Currently open trials in the same condition.

NCT05300685 — Peri-operative Oral Pain Control Following Buccal Graft Urethroplasty · Phase 3 · recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06123520 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 8 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06123520.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing